Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
Identification of the Cytokines, Growth Factors and Their Receptors Expressed by Human Blood Eosinophils: A Transcriptomics Approach. [PDF]
Esnault S +10 more
europepmc +1 more source
Association Between Serum Growth Factors and Risk of Acute Exacerbation in Chronic Obstructive Pulmonary Disease: A One-Year Prospective Study. [PDF]
Tien HY, Chen CY, Yu CJ, Wang HC.
europepmc +1 more source
Preadipocyte Uncoupling Protein 1 Expression Invoked by Fibroblast Growth Factors Imprints on Post-Differentiation White and Brown Adipocyte Phenotype. [PDF]
Kuellmer K +8 more
europepmc +1 more source
From Growth Factors to Structure: PDGF and TGF-β in Granulation Tissue Formation. A Literature Review. [PDF]
Irma J +5 more
europepmc +1 more source
Combination of knockout serum replacement and plasma rich in growth factors does not support in vitro spermatogenesis in mice. [PDF]
Moradian SA +3 more
europepmc +1 more source
Serum Behavior of NT-3 and VEGFβ, Two Unstudied Growth Factors in Patients with Diabetes Mellitus and End-Stage Renal Disease. [PDF]
Gheorghiu M +4 more
europepmc +1 more source

